Real life studies: call for census from the HAS
The collection of real-life data[1] is a central issue for the evaluation of medicinal products and medical devices. On the one…
Reimbursement of innovative medicinal products : the new criterion of relative therapeutic value
Introduced in the Senate on November 25, 2021, the bill on health innovation aims to improve the conditions of access…
man reject gift
“Anti-gift” scheme: figures for the year 2021
The French National Medical Council has published its annual report for the year 2021, in which a section is devoted…
Can a medicinal product be required to be treated identically to other specialties?
The principle of equality requires the administration to settle identical situations in an identical manner[1]. In a decision dated April 6,…
Early access and compassionate access : how should industry compensate healthcare institutions for data collection?
It will be recalled that one of the main contributions of the LFSS for 2021 is the total overhaul of…
Medical devices, accessories, products for cosmetics use : what changes from now on ?
Ordinance No. 2022-582 of April 20, 2022 adapting French law to Regulation (EU) 2017/745 of the European Parliament and of…